inhoudelijk LIGHT Gilead downgraded to Neutral from Buy at Citi. Citi analyst Robyn Karnauskas downgraded Gilead Sciences to Neutral and lowered her price target for the shares to $75 from $100.CITI Gilead Without N... Forumberichten 12 feb | Door: Wall Street Trader Forum: Galapagos
Galapagos december 2018 Because of all the crap on this thread are first post and hint before the FINCH-2 data came out only got picked up by Piddybull. So shout out to you.In are first post we forgot to mention Lama Dail... Forumberichten 30 nov | Door: Wall Street Trader Forum: Galapagos
Galapagos augustus 2018 We expect Gilead to present topline results of the FINCH-2 study set at the next ACR conference, 19th-24th October 2018Shout out to: Biotech Radar, pe26, Volker Schulz, BioStockAddict, NielsjeB, Vo... Forumberichten 09 aug | Door: Wall Street Trader Forum: Galapagos